Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
Social and economic burden of walking and mobility problems in multiple sclerosis.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
Role of the Human Endogenous Retrovirus HERV-K18 in Autoimmune Disease Susceptibility: Study in the Spanish Population and Meta-Analysis.
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.
[Autonomic neuropathies].
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.
Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis.
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
Multiple sclerosis: Effect of smoking on antibody response to IFN-β treatment.
Leukoencephalopathy due to Oral Methotrexate.
Second generation S1P pathway modulators: Research strategies and clinical developments.
Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.
Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using optical coherence tomography.
Is metabolic flexibility altered in multiple sclerosis patients?
Robotic therapy: the tipping point.
Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.
Comparison of the effect of baclofen and transcutaneous electrical nerve stimulation for the treatment of spasticity in multiple sclerosis.
Characterising aggressive multiple sclerosis.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
Driving competences and neuropsychological factors associated to driving counseling in multiple sclerosis.
Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication.
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.

Pages